Health Policy Section, Department of Nursing, Faculty of Medical Technology, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-1211, Japan.
Center for Preventive Medicine, St. Luke's International Hospital, 8-1 Akashi-cho Chuo-ku, Tokyo 104-6591, Japan.
Asian Pac J Cancer Prev. 2021 Jun 1;22(6):1695-1702. doi: 10.31557/APJCP.2021.22.6.1695.
Although cervical cancer screening has been performed as a national program since 1983 in Japan, the participation rate has remained below 20%. Equity of access is a basic requirement for cancer screening. However, taking smears from the cervix has been limited to gynecologists or obstetricians in Japan and it might be a barrier for accessibility. We examined the current access and its available human resources for cervical cancer screening in Japan.
We analyzed the number of gynecologists and obstetricians among 47 prefectures based on a national survey. A systematic review was performed to clarify disparity and use of human resources in cervical cancer screening, diagnosis, and treatment for cervical cancers in Japan. Candidate literature was searched using Ovid-MEDLINE and Ichushi-Web until the end of January 2020. Then, a systematic review regarding accessibility to cervical cancer screening was performed. The results of the selected articles were summarized in the tables.
Although the total number of all physicians in Japan increased from 1996 to 2016, the proportion of gynecologists and obstetricians has remained at approximately 5% over the last 2 decades. 43.6% of municipalities have no gynecologists and obstetricians in 2016. Through a systematic review, 4 English articles and 1 Japanese article were selected. From these 5 articles, the association between human resources and participation rates in cervical cancer screening was examined in 2 articles.
The human resources for taking smears for cervical cancer screening has remained insufficient with a huge disparity among municipalities in Japan. To improve accessibility for cervical cancer screening another option which may be considered could be involving general physicians as potential smear takers.
自 1983 年以来,日本一直在开展宫颈癌筛查的国家计划,但参与率仍低于 20%。公平获得癌症筛查是基本要求。然而,在日本,从宫颈取涂片的工作仅限于妇科医生或产科医生,这可能是获得服务的障碍。我们检查了日本目前宫颈癌筛查的可及性及其可利用的人力资源。
我们根据一项全国性调查,分析了 47 个都道府县的妇科医生和产科医生人数。为了明确日本宫颈癌筛查、诊断和治疗中人力资源的差异和利用情况,我们进行了系统评价。使用 Ovid-MEDLINE 和 Ichushi-Web 检索候选文献,检索截至 2020 年 1 月底。然后,对宫颈癌筛查的可及性进行了系统评价。所选文章的结果总结在表格中。
尽管日本的所有医生总数从 1996 年增加到 2016 年,但妇科医生和产科医生的比例在过去 20 年中一直保持在 5%左右。2016 年,有 43.6%的市町村没有妇科医生和产科医生。通过系统评价,共选择了 4 篇英文文章和 1 篇日文文章。从这 5 篇文章中,有 2 篇文章检查了人力资源与宫颈癌筛查参与率之间的关系。
日本在人力资源方面,用于宫颈癌筛查的涂片工作仍然不足,而且各都道府县之间存在巨大差异。为了提高宫颈癌筛查的可及性,可以考虑另一种选择,即让普通医生作为潜在的涂片采集者。